fda shortage semaglutide injection resolved feb 21 2025 End of Means Big Changes for Prescribers and Compounders As of February 21, 2025,

After reviewing your full health history, including any relevant medical conditions such as a personal or family history of thyroid C-cell tumors, and performing an individual assessment of your starting weight and aesthetic goals, your healthcare provider will determine whether participation is clinically appropriate

Hypoglycemia Risk : When used in combination with insulin or insulin secretagogues (like sulfonylureas), there is an increased risk of hypoglycemia

This means the day after early dosing is when you are most likely to feel enhanced side effects

Conversely, administering the medication at night might be preferable for individuals who observe minimal side effects or find that the drug helps mitigate their nighttime cravings

Are ready to commit to a healthier lifestyle with professional guidance

The FDA has ruled the shortage of these brand name medications has been resolved effective 05/22/2025